Physician profile
Robert Klein
NPI 1861455503
$3,758.58
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $195 · 2021: $588 · 2022: $322 · 2023: $1,626 · 2024: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,241 · Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,241.30 |
| Food and Beverage | $554.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $1,241.30 | 2023 | Activ.A.C. |
| Abbvie INC. | $737.11 | 2019-2024 | |
| Exeltis, USA INC. | $649.70 | 2019-2021 | |
| Hologic Sales and Service, LLC | $191.88 | 2019-2024 | Aptima, Affirm Prone Biopsy System, Third Wave |
| Pfizer INC. | $134.37 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $104.03 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.75 | 2019-2023 | |
| Therapeuticsmd, INC. | $76.48 | 2019-2021 | |
| Exact Sciences Corporation | $65.63 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $62.19 | 2021-2022 | |
| Agile Therapeutics, INC. | $48.45 | 2021-2022 | |
| Kerecis Limited | $48.24 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Allergan, INC. | $40.51 | 2019-2020 | |
| Aspira Women'S Health INC | $35.39 | 2019 | |
| Coopersurgical, INC. | $28.88 | 2021-2023 | Summit Doppler |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.58 | 2022 | |
| Mission Pharmacal Company | $20.66 | 2019 | |
| Roche Diagnostics Corporation | $20.54 | 2021 | |
| Smith+Nephew, INC. | $19.70 | 2022 | |
| Optumhealth Care Solutions, LLC | $19.35 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Lupin INC. | $16.63 | 2019 | |
| Ascend Therapeutics US, LLC | $16.00 | 2021 | |
| Shield Therapeutics INC | $15.63 | 2022 | |
| Becton, Dickinson and Company | $14.87 | 2024 | Bd Onclarity |
| Avion Pharmaceuticals | $14.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.